Biacore: Extraordinary General Meeting September 7, 2006.

UPPSALA, Sweden -- Biacore International AB (Nasdaq:BCOR)(STO:BCOR) announces today its decision to invite the shareholders of Biacore International AB to an Extraordinary General Meeting of shareholders on September 7, 2006. A notice of the AGM is attached.

About Biacore

Biacore is a global supplier of systems for protein interaction analysis, an area of increasing importance for scientists in the academic, pharmaceutical, biotechnology and diagnostic markets. The Company's systems generate unique data on the interactions between proteins and other molecules, including small molecules such as drug candidates. During research, development and manufacture, these data give insights into protein functionality, elucidate disease mechanisms and play a key role in the critical decisions needed for efficient development and production of therapeutics.

Biacore's products are used in key areas such as antibody characterization, proteomics, lead characterization, immunogenicity, biotherapeutic development and production. The Company offers a range of products to meet specific application needs. Customers include leading life science research centers, all of the leading global pharmaceutical companies, and a large number of companies in the emerging biotechnology sector.

Biacore also markets food analysis solutions, providing key manufacturers with a system and ready-to-use kits for the determination of food quality and safety.

The Company has its own direct sales capability in the world's key markets (United States, Europe, Japan, Australia) and a distribution network in Asia-Pacific. Biacore was founded in 1984 and is listed on the Stockholm Stock Exchange (SSE:BCOR).

Biacore is a trademark of Biacore AB.

Further information on Biacore can be found at: www.biacore.com

This is an unofficial translation of the Swedishoriginal notice. In case of differences between the Swedish version and the English translation, the Swedish version shall prevail.

Notice of the Extraordinary General Meeting of Shareholders on Thursday, September 7, 2006

Notice is hereby given to the shareholders in Biacore International AB (publ) of the Extraordinary General Meeting of Shareholders to be held on Thursday, September 7, 2006 at 4:30 p.m. at the premises of Biacore International AB, Rapsgatan 7, Uppsala

Participation

Shareholders who wish to participate in the General Meeting must

- be recorded in the share register kept by VPC AB (the Swedish Securities Register Center) on Friday, September 1, 2006, and

- notify Biacore International AB, Rapsgatan 7, SE-754 50 Uppsala, Sweden, by telephone [phone], fax [phone] or e-mail [e-mail], no later than 4 p.m. on Friday, September 1, 2006. When giving notice of attendance, the shareholder should state name and personal identity number (date of birth) or company registration number. The shareholder may be represented by an authorized representative and may bring one or two assistants. The shareholder must notify the company as regards the number of assistants within the time limit set out above. Representatives should attach to their notice of attendance documents verifying their due authorization, such as certificate of registration for legal entities.

Shareholders whose shares are held in the name of a trustee must temporarily re-register their shares in their own names in order to be entitled to participate in the meeting. Such re-registration must be effected with VPC on Friday, September 1, 2006. The shareholders should notify their trustees in ample time.

Matters to be dealt with at the meeting

Proposed agenda

1. Opening of the meeting.

2. Election of Chairman for the Meeting.

3. Preparation and approval of voting list.

4. Election of one or two persons to verify the minutes.

5. Approval of the agenda.

6. Resolution as to whether the meeting has been duly convened.

7. Resolution as to the number of Directors and the remuneration payable to the Board of Directors.

GE Healthcare, through Goldcup D 1879 AB, under change of name to GE Healthcare Holding AB, holding in excess of 98 per cent of the shares after the public tender offer, makes the following proposal:

The number of Directors of the Board is proposed to be three (3) without alternate Directors. No remuneration is proposed to be granted to the Directors.

8. Election of Directors.

GE Healthcare, through Goldcup D 1879 AB, under change of name to GE Healthcare Holding AB, holding in excess of 98 per cent of the shares after the public tender offer, makes the following proposal:

The following persons are proposed to serve as Board members for the period up to the Annual General Meeting 2007: Peter Ehrenheim, James Martin and Ulf Linden. Peter Ehrenheim is proposed to serve as Chairman of the Board. All proposed Board members are for new election.

9. Conclusion of the Meeting.

Uppsala in August 2006

Biacore International AB (publ)

The Board of Directors

This information was brought to you by Waymaker http://www.waymaker.net